Upgrade to SI Premium - Free Trial

Amicus Therapeutics (FOLD) PT Lowered to $19 at Morgan Stanley

May 9, 2024 12:03 PM
Morgan Stanley analyst Jeffrey Hung lowered the price target on Amicus Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles